Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Downgrades Oncorus to Neutral

HC Wainwright & Co. Downgrades Oncorus to Neutral

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Oncorus (NASDAQ:ONCR) from Buy to Neutral.

byBenzinga Newsdesk

December 6, 2022

1 minute read

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Oncorus (NASDAQ:ONCR) from Buy to Neutral.

Analyst Ratings

10 Analysts Have This To Say About Qorvo

By Benzinga Insights

June 12, 9:00 AM

Providing a diverse range of perspectives from bullish to bearish, 10 analysts have published ratings on Qorvo (NASDAQ:QRVO)…

QRVO

Reported Late Tuesday, iBio Announces Pricing Of $3.5M Underwritten Public Offering Of 3,365,385 Shares Of Common Stock At A Price Of $1.04/Share

By Benzinga Newsdesk

December 7, 2:32 AM

iBio, Inc. (NYSEA: IBIO) ("iBio" or the "Company"), an AI-driven innovator of precision antibody immunotherapies, today announced the pricing of its previously announced underwritten public offering

IBIO

Analyst Ratings

EF Hutton Maintains Buy Rating for Innovative Solns: Here’s What You Need To Know

By Benzinga Insights

October 13, 1:00 PM

EF Hutton has decided to maintain its Buy rating of Innovative Solns (NASDAQ:ISSC) and lower its price target…

ISSC

News
Tech

Five Tips To Automakers By Women To Make EVs More Appealing To Women

By Anan Ashraf

July 18, 10:33 AM

Four women discussed why women do not try electric vehicles in a discussion held on the ground of…

HC Wainwright & Co. Downgrades Oncorus to Neutral

Related Posts

10 Analysts Have This To Say About Qorvo

Reported Late Tuesday, iBio Announces Pricing Of $3.5M Underwritten Public Offering Of 3,365,385 Shares Of Common Stock At A Price Of $1.04/Share

EF Hutton Maintains Buy Rating for Innovative Solns: Here’s What You Need To Know

Five Tips To Automakers By Women To Make EVs More Appealing To Women